NCT05061732

Helicobacter Pylori Eradication and Follow-up

Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 4,447 (estimated)
• Sponsor: Shanghai Zhongshan Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This randomized controlled clinical trial will estimate the eradication efficacy of different therapy for Helicobacter pylori treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.

Conditions

• Helicobacter Pylori Infection

Interventions

Type	Name	Description
DRUG	Rabeprazole	20mg bid
DRUG	Bismuth potassium citrate	0.6g bid
DRUG	Metronidazole	0.4g qid
DRUG	Clarithromycin	0.5g bid
DRUG	Levofloxacin	0.5g qd
DRUG	Amoxicillin	1g tid
DRUG	Metronidazole	0.4g tid
DRUG	Doxycycline	0.1g bid
DRUG	Tetracycline	0.5g qid

Timeline

• Start date: 2021-09-30
• Primary completion: 2026-06-30
• Completion: 2026-06-30
• First posted: 2021-09-30
• Last updated: 2021-09-30

Locations

1 site across 1 country: China